Oncology Pharma (ONPH) Short Interest Ratio & Short Volume → Special FREE offer on stock hotsheets (From DTI) (Ad) Free ONPH Stock Alerts $0.0005 0.00 (0.00%) (As of 04/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Oncology Pharma Short Interest DataCurrent Short Volume13,500 sharesPrevious Short Volume13,500 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$1.35Short Interest Ratio / Days to Cover4.5Last Record DateMarch 31, 2024Outstanding Shares38,660,000 sharesPercentage of Shares Shorted0.03%Today's Trading Volume540 sharesAverage Trading Volume8,054 sharesToday's Volume Vs. Average7% Short Selling Oncology Pharma ? Sign up to receive the latest short interest report for Oncology Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatONPH Short Interest Over TimeONPH Days to Cover Over TimeONPH Percentage of Float Shorted Over Time Ad Priority GoldBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. Oncology Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202413,500 shares $1.35 No ChangeN/A4.5 $0.00 3/15/202413,500 shares $0.00 -0.7%N/A1.7 $0.00 2/29/202413,600 shares $0.00 No ChangeN/A2.4 $0.00 2/15/202413,600 shares $0.00 No ChangeN/A2.7 $0.00 1/15/202413,600 shares $0.00 No ChangeN/A3 $0.00 12/31/202313,600 shares $2.72 -4.9%N/A0.1 $0.00 Get the Latest News and Ratings for ONPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncology Pharma and its competitors with MarketBeat's FREE daily newsletter. 12/15/202314,300 shares $2.86 -10.1%N/A0.3 $0.00 11/30/202315,900 shares $15.90 -52.0%N/A1 $0.00 11/15/202333,100 shares $33.10 -32.2%N/A2.7 $0.00 10/31/202348,800 shares $976.00 -17.2%N/A10 $0.02 10/15/202358,900 shares $2,208.75 -35.5%N/A6.5 $0.04 9/30/202391,300 shares $5,934.50 -1.0%N/A13.8 $0.07 9/15/202392,200 shares $4,378.58 -1.4%N/A10.5 $0.05 8/31/202393,500 shares $2,337.50 +523.3%N/A4.3 $0.03 8/15/202315,000 shares $4,275.00 -6.8%N/A0.2 $0.29 7/31/202316,100 shares $5,726.77 +16.7%N/A0.3 $0.36 7/15/202313,800 shares $5,422.02 -21.1%N/A0.3 $0.39 6/30/202317,500 shares $5,600.00 +19.9%N/A0.1 $0.32 6/15/202314,600 shares $8,176.00 -3.3%N/A0 $0.56 5/31/202315,100 shares $2,114.00 -22.6%N/A0.1 $0.14 5/15/202319,500 shares $2,730.00 +20.4%N/A0.1 $0.14 4/30/202316,200 shares $2,592.00 -30.5%N/A0.1 $0.16 4/15/202323,300 shares $3,902.75 -14.7%N/A0.2 $0.17 3/31/202327,300 shares $5,050.50 +45.2%N/A0.1 $0.19 3/15/202318,800 shares $5,452.00 -25.1%N/A0.2 $0.29 2/28/202325,100 shares $9,086.20 +9.6%N/A0.4 $0.36 2/15/202322,900 shares $8,702.00 -24.7%N/A0.2 $0.38 1/31/202330,400 shares $11,704.00 +28.8%N/A0.3 $0.39 1/15/202323,600 shares $9,676.00 -32.2%N/A0.1 $0.41 12/30/202234,800 shares $11,781.89 +5.1%N/A0.1 $0.34 12/15/202233,100 shares $16,881.00 -3.2%N/A0.2 $0.51 11/30/202234,200 shares $24,538.50 -6.8%N/A0.6 $0.72 11/15/202236,700 shares $34,131.00 -35.8%N/A0.2 $0.93 10/31/202257,200 shares $50,845.08 -5.9%N/A0.5 $0.89 10/15/202260,800 shares $26,144.00 -60.2%N/A0.4 $0.43 9/30/2022152,700 shares $70,242.00 +2.9%N/A1 $0.46 9/15/2022148,400 shares $129,093.16 +1.0%N/A2.5 $0.87 8/31/2022146,900 shares $149,838.00 -0.2%N/A1.6 $1.02 8/15/2022147,200 shares $198,720.00 -14.6%N/A1.3 $1.35 7/31/2022172,400 shares $231,016.00 -6.7%N/A1.1 $1.34This company has increased its dividend every year for 54 years (Ad)There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.Click here to get them (for Free). ONPH Short Interest - Frequently Asked Questions What is Oncology Pharma's current short interest? Short interest is the volume of Oncology Pharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 13,500 shares of ONPH short. Learn More on Oncology Pharma's current short interest. What is a good short interest ratio for Oncology Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ONPH shares currently have a short interest ratio of 4.0. Learn More on Oncology Pharma's short interest ratio. How does Oncology Pharma's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Oncology Pharma: Bruush Oral Care Inc. (62.06%), RenovaCare, Inc. (0.00%), CVR Medical Corp. (0.03%), Amarantus BioScience Holdings, Inc. (0.00%), ReNeuron Group plc (0.00%), Propanc Biopharma, Inc. (0.01%), Resonate Blends, Inc. (0.11%), Leafly Holdings, Inc. (1.15%), CareCloud, Inc. (1.34%), Definitive Healthcare Corp. (15.57%), and Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Oncology Pharma stock? Short selling ONPH is an investing strategy that aims to generate trading profit from Oncology Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Oncology Pharma? A short squeeze for Oncology Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ONPH, which in turn drives the price of the stock up even further. How often is Oncology Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONPH, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Bruush Oral Care Short Squeeze RenovaCare Short Squeeze CVR Medical Short Squeeze Amarantus BioScience Short Squeeze ReNeuron Group Short Squeeze Propanc Biopharma Short Squeeze Resonate Blends Short Squeeze Leafly Short Squeeze CareCloud Short Squeeze Definitive Healthcare Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ONPH) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceTop 5 AI Stocks to Buy for 2024Market Moving TrendsHow Biden has already won 2024Porter & Company